Revive Therapeutics Ltd. (31R)
Market Closed
3 Jun, 20:00
XFRA 
€
0. 0130
+0.006
+85.71%
€
- Market Cap
- P/E Ratio
- Div Yield
1,400 Volume
- Eps
€ 0.007
Previous Close Want to track 31R and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
31R Earnings Reports FAQ
What is the earnings per share (EPS) for 31R?
EPS data for 31R is currently not available, as Revive Therapeutics Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Revive Therapeutics Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Revive Therapeutics Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Revive Therapeutics Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 31R at this time, as Revive Therapeutics Ltd has no recent EPS data to calculate it.
